Dr. Brian Cameron, MD
Neurosurgery (Neurological Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Virginia Commonwealth University, School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 305
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Virginia Commonwealth University, School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurological Surgery Physician primary
VA license 0101241992
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Sentara Williamsburg Regional Medical Center Williamsburg, VA
- Vcu Health Tappahannock Hospital Tappahannock, VA
- Riverside Doctors' Hospital of Williamsburg Williamsburg, VA
- Community Memorial Hospital South Hill, VA
Medical groups
- Mcv Associated Physicians (1,807 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 305
- Services billed
- 687
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 175 | 140 |
| New patient office or other outpatient visit, 45-59 minutes | 98 | 98 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 76 | 41 |
| Fusion of additional segment of spine | 61 | 20 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 39 | 39 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 23 | 15 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 18 | 17 |
| Placement of stabilizing device to back, 3-6 spine bone segments | 18 | 18 |
| Computer-assisted spinal procedure | 16 | 16 |
| Placement of stabilizing device to back of 1 spine bone in neck | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $17.99 in total to this clinician.
| Vb Spine LLC | $17.99 |
|---|
| Food and Beverage | $17.99 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $66,088 in research payments for these studies, mostly to the institutions running them.
- Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
AbbVie Inc. · Completed · NCT04295538 - A Prospective, Multicenter Study to Evaluate the Performance and Safety of the CerebroFlo EVD Catheter
Integra Lifesciences Corporation - M16-077 - Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.